News

Get to know what's happening behind the scenes.

Learn more

Featured

Blog

Read the latest on our blog. Let's Talk Innovation.

Social

Stay connected with us on social media.

twitter_logo_20px.jpg @JNJinnovation

Events

Press Releases

Read our latest news.

  • FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A Led by Johnson & Johnson Innovation

  • Ethicon Announces Agreement to Acquire Torax Medical, Inc.

  • S-Biomedic joins the JLINX Community

    Beerse, Belgium
    February 9, 2017

    S-Biomedic, an early stage biotech company focused on skin microbiome, has secured financing enabling the company to advance its lead product for acne patients.

    S-Biomedic has developed a method to directly modulate the skin microbiome, with applications in dermatology and the cosmetic industry. The skin microbiome, a habitat of billions of good and bad bacteria, contributes to conditions ranging from acne, eczema and rosacea to ageing. The company was founded by Veronika Oudova, Bernhard Pätzold and Marc Güell and is located at the JLINX facilities in Beerse, Belgium. 

Pages

Accelerators

Close
Neomed (Montreal)
7171 Frederick-Banting
Montreal, Quebec, CANADA H4S 1Z9
(514) 367 1212
mail@www.neomed.ca
www.neomed.ca
Your web browser is out of date. For the most optimal experience, please upgrade to the newest version of IE. Thank You.